Navigation Links
RSB Spine, LLC, Announces FDA Clearance for Its InterPlate(TM) C-PS and L-PS Interbody Spacers

CLEVELAND, Jan. 28 /PRNewswire/ -- RSB Spine, LLC, today announced that the U.S. Food and Drug Administration has approved the company's 510(k) application to permit the marketing of its InterPlate™ C-PS and L-PS Interbody Spacers.

RSB Spine Chief Executive Officer John A. Redmond said: "We are very excited about this new clearance, since it gives our distributors two additional products to offer customers seeking greater options in Zero-Profile® technologies. Our InterPlate portfolio now provides surgeons with the most unique implant combinations on the market."

"Zero-Profile technologies comprise one of the fastest growing segments in the spinal industry," said Mike O'Neill, president of Paradigm BioDevices. "RSB Spine is the only company with a full-line modular interbody platform offering a complete array of material and mechanical loading options that is also code compliant."

RSB Spine is a privately held medical device company focused on developing innovative spinal implants with a focus on modular fusion products. News releases and other information on the company are available on the Internet at:

Zero-Profile® is a registered Service Mark of Paradigm BioDevices, Inc., Rockland, MA.




Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
2. RSB Spine, LLC Announces First Implantation of the InterPlate(TM) L for the Lumbar Spine
3. Drug Safety Firm BioSoteria Announces Exponential Growth in 2009
4. Sinovac Announces Upsizing and Pricing of Common Share Offering
5. Sudek of Tech Coast Angels Announces Networks Increased Commitment to Entrepreneurship and Innovation Through New Easy-Access Programs
6. Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited
7. YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USA
8. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
9. Firmex Announces Virtual Data Room Enhancements for Large Projects
10. UMass Boston's Venture Development Center Announces New Bio-Science Partner
11. Healthcare Data Solutions Announces New Mobile Application, PrescriberPRO Mobile
Post Your Comments:
(Date:11/24/2015)... SUNNYVALE, Calif. , Nov. 24, 2015 ... executives will be speaking at the following conference, and ... New York, NY      Tuesday, December 1, ... New York, NY      Tuesday, December 1, ...      Piper Jaffray Healthcare Conference, New York, NY ...
(Date:11/24/2015)... ... November 24, 2015 , ... International Society for ... of the premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. The conference ... ISPE hosted the largest number of attendees in more than a decade. ...
(Date:11/24/2015)... ... ... This fall, global software solutions leader SAP and AdVenture Capital brought together dozens ... BIG ideas to improve health and wellness in their schools. , Now, the top ... of SAP's Teen Innovator, an all-expenses paid trip to Super Bowl 50, and an ...
(Date:11/24/2015)... Technologies Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of ... Israel time, at the law offices of Goldfarb ... Floor, Tel Aviv, Israel . ... Tamir to the Board of Directors; , election of ... of an amendment to certain terms of options granted to our Chief ...
Breaking Biology Technology:
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
(Date:11/12/2015)... Nov. 11, 2015   Growing need for ... tools has been paving the way for use ... of discrete analytes in clinical, agricultural, environmental, food ... predominantly used in medical applications, however, their adoption ... due to continuous emphasis on improving product quality ...
Breaking Biology News(10 mins):